Classification for Medical Devices and Accessories
CLASSIFICATION IS MORE THAN A CODE
Import classification is more than selecting a tariff code. Intended use, FDA entry data, and product classification must align to support compliant medical device imports.
Import classification for a medical device is not a single decision. The entry must consistently describe what the product is, what it does, why it is entering the United States, and how it is presented. FDA product codes, FDA import data, tariff classification, invoice descriptions, and supporting documents should tell the same regulatory and commercial story.
Intended use is often the controlling issue. A device imported for ordinary commercial distribution is not situated in the same way as the same device imported for a clinical investigation, bench testing, customer evaluation, exhibition, repair and re-export, personal use, or further manufacturing. Labels, instructions for use, study documents, technical specifications, shipment quantities, consignee identity, and the destination facility should support the declared purpose.
Classification Goes Beyond the Device
This distinction is made operational through FDA Intended Use Codes, or IUCs, transmitted through the Automated Commercial Environment. An IUC is mandatory for a medical-device entry line and identifies the import scenario. It also determines which Affirmations of Compliance and supporting identifiers the filer must provide.
Classification Errors Trigger FDA Review
Selecting the wrong IUC is not a harmless coding error. If a device that lacks U.S. marketing authorization is being imported for a clinical investigation but is entered as a standard commercial import, FDA may evaluate it as though it is being offered for ordinary distribution. The entry may then appear to be missing required establishment registration, device listing, premarket authorization, or other commercial-import information. That mismatch can lead to questions, document requests, examination, delay, detention, or refusal unless it is promptly and adequately resolved. The investigational basis, including the applicable Investigational Device Exemption (IDE) information or other documentation supporting the study status, should therefore be confirmed before shipment. FDA specifically warns that an incorrect IUC can cause other entry data to be incorrect and delay initial review and screening.
Construction, accessories, and unit presentation remain relevant. A charger, controller, cable, disposable, software-loaded computer, replacement component, or procedure kit may require treatment different from the parent device. Likewise, a complete system, individual replenishment item, unfinished component, demonstration unit, and clinical-study kit may need different product descriptions, codes, and supporting records.
MDD Options can incorporate import-classification control into both clinical-investigation support and its hybrid U.S. distribution model. This includes mapping each SKU and shipment scenario, confirming the correct IUC and FDA data, aligning invoices and study documentation, and giving customs brokers shipment-specific instructions before dispatch. This reduces preventable holds and helps ensure that investigational, commercial, and other special-purpose imports are presented consistently.